Literature DB >> 26614871

Ribosomal Protein S6 Phosphorylation: Four Decades of Research.

Oded Meyuhas1.   

Abstract

The phosphorylation of ribosomal protein S6 (rpS6) has been described for the first time about four decades ago. Since then, numerous studies have shown that this modification occurs in response to a wide variety of stimuli on five evolutionarily conserved serine residues. However, despite a large body of information on the respective kinases and the signal transduction pathways, the physiological role of rpS6 phosphorylation remained obscure until genetic manipulations were applied in both yeast and mammals in an attempt to block this modification. Thus, studies based on both mice and cultured cells subjected to disruption of the genes encoding rpS6 and the respective kinases, as well as the substitution of the phosphorylatable serine residues in rpS6, have laid the ground for the elucidation of the multiple roles of this protein and its posttranslational modification. This review focuses primarily on newly identified kinases that phosphorylate rpS6, pathways that transduce various signals into rpS6 phosphorylation, and the recently established physiological functions of this modification. It should be noted, however, that despite the significant progress made in the last decade, the molecular mechanism(s) underlying the diverse effects of rpS6 phosphorylation on cellular and organismal physiology are still poorly understood.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell proliferation; Cell size; Glucose homeostasis; Protein synthesis; RSK; Ribosomal protein S6; S6 kinase; Tumorigenicity; mTOR

Mesh:

Substances:

Year:  2015        PMID: 26614871     DOI: 10.1016/bs.ircmb.2015.07.006

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  100 in total

1.  Lysosome Membrane Permeabilization and Disruption of the Molecular Target of Rapamycin (mTOR)-Lysosome Interaction Are Associated with the Inhibition of Lung Cancer Cell Proliferation by a Chloroquinoline Analog.

Authors:  Juan Sironi; Evelyn Aranda; Lars Ulrik Nordstrøm; Edward L Schwartz
Journal:  Mol Pharmacol       Date:  2018-11-08       Impact factor: 4.436

2.  Alterations in Phosphorylation of Hepatocyte Ribosomal Protein S6 Control Plasmodium Liver Stage Infection.

Authors:  Elizabeth K K Glennon; Laura S Austin; Nadia Arang; Heather S Kain; Fred D Mast; Kamalakannan Vijayan; John D Aitchison; Stefan H I Kappe; Alexis Kaushansky
Journal:  Cell Rep       Date:  2019-03-19       Impact factor: 9.423

3.  mTORC1/rpS6 signaling complex modifies BTB transport function: an in vivo study using the adjudin model.

Authors:  Ming Yan; Linxi Li; Baiping Mao; Huitao Li; Stephen Y T Li; Dolores Mruk; Bruno Silvestrini; Qingquan Lian; Renshan Ge; C Yan Cheng
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-05-21       Impact factor: 4.310

Review 4.  An emerging role for the ribosome as a nexus for post-translational modifications.

Authors:  Deniz Simsek; Maria Barna
Journal:  Curr Opin Cell Biol       Date:  2017-04-23       Impact factor: 8.382

5.  mTOR Senses Intracellular pH through Lysosome Dispersion from RHEB.

Authors:  Zandra E Walton; Rebekah C Brooks; Chi V Dang
Journal:  Bioessays       Date:  2019-06-03       Impact factor: 4.345

6.  F5-Peptide and mTORC1/rpS6 Effectively Enhance BTB Transport Function in the Testis-Lesson From the Adjudin Model.

Authors:  Baiping Mao; Linxi Li; Ming Yan; Chris K C Wong; Bruno Silvestrini; Chao Li; Renshan Ge; Qingquan Lian; C Yan Cheng
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

7.  DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis.

Authors:  Pedro Barroso-Chinea; Diego Luis-Ravelo; Felipe Fumagallo-Reading; Javier Castro-Hernandez; Josmar Salas-Hernandez; Julia Rodriguez-Nuñez; Alejandro Febles-Casquero; Ignacio Cruz-Muros; Domingo Afonso-Oramas; Pedro Abreu-Gonzalez; Rosario Moratalla; Mark J Millan; Tomas Gonzalez-Hernandez
Journal:  Autophagy       Date:  2019-10-02       Impact factor: 16.016

8.  The mTOR Substrate S6 Kinase 1 (S6K1) Is a Negative Regulator of Axon Regeneration and a Potential Drug Target for Central Nervous System Injury.

Authors:  Hassan Al-Ali; Ying Ding; Tatiana Slepak; Wei Wu; Yan Sun; Yania Martinez; Xiao-Ming Xu; Vance P Lemmon; John L Bixby
Journal:  J Neurosci       Date:  2017-06-16       Impact factor: 6.167

9.  Phosphorylation of Arabidopsis eIF4E and eIFiso4E by SnRK1 inhibits translation.

Authors:  Aaron N Bruns; Sizhun Li; Gireesha Mohannath; David M Bisaro
Journal:  FEBS J       Date:  2019-06-03       Impact factor: 5.542

Review 10.  Mammalian target of rapamycin complex (mTOR) pathway modulates blood-testis barrier (BTB) function through F-actin organization and gap junction.

Authors:  Nan Li; C Yan Cheng
Journal:  Histol Histopathol       Date:  2016-03-09       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.